Generic Drugs Market Research Reports & Industry Analysis
Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand-name drugs. These low-cost alternatives must contain the same active chemical ingredient and rate of absorption as the branded product. Due to high demand an increase in the number of generic drug approvals, the global generic drugs market has expanded at a steady pace over the years, and new growth opportunities are anticipated in the future. Check out our research collection to learn more about this lucrative market.
New Generic Drugs Industry Research
- Find quality data on industries big and small, whether you are interested in a specific product, region, or country.
- Gain in-depth research on generic drug market segmentation, patents, clinical trials, funding, and regulatory framework.
- Discover valuable new market opportunities, pockets of growth, and strategies to sustain success.
A Trusted Name in Research
MarketResearch.com offers a wealth of resources to propel your success through data-driven decision-making. We are proud to serve top investment banks, management consulting firms, leading life science companies, and universities—with a track record spanning decades and an experienced team to support your research needs. Explore our generic drugs industry reports today and embrace the power of foresight in an evolving market.
Generics Drugs Industry Research & Market Reports
-
India Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Parenteral, Topical, Others), By Form (Tablets, Capsules, Injections, Others), By Source (Contract Manufacturing Organizations v/s In-house), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), By Application (Neurology, Oncology, Cardiovascular Diseases, Diabetes, Anti-Inflammatory Diseases, Others), By Region, Competition, Forecast & Opportunities, 2018-2028F
... Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), By Application (Neurology, Oncology, Cardiovascular Diseases, Diabetes, Anti-Inflammatory Diseases, Others), By Region, Competition, Forecast & Opportunities, 2018-2028F India generic drugs market stood at USD 24.53 Billion in ... Read More
-
Global Generic Injectables Market 2022-2028
... metabolism. The global generic injectables market size is projected to grow by USD 49 billion from 2022 to 2028, registering a CAGR of 8.7 percent, according to a new report by Gen Consulting Company. The ... Read More
-
Generic Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery
... and senior management with the critical information they need to assess the global generic pharmaceuticals market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Branded Generics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The global branded generics market is projected to reach ... Read More
-
Global Regulatory Affairs Outsourcing Market Size study, by Services (Regulatory Consulting, Legal Representation, Regulatory Writing & Publishing, Product Registration & Clinical Trial Applications, Other Services) by Company Size (Small, Medium, Large) by Category (Drugs, Generics, Innovators, Biologics, Biotech, ATMPs, Biosimilars, Medical devices, Therapeutic, Diagnostic) by Indication (Oncology, Neurology, Cardiology, Immunology, Others) by Stage (Preclinical, Clinical, PMA (Post Market Authorization)) by End-use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies) and Regional Forecasts 2022-2028
... Innovators, Biologics, Biotech, ATMPs, Biosimilars, Medical devices, Therapeutic, Diagnostic) by Indication (Oncology, Neurology, Cardiology, Immunology, Others) by Stage (Preclinical, Clinical, PMA (Post Market Authorization)) by End-use (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies) and Regional ... Read More
-
Pharmaceutical Contract Development & Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Injectable, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing}, End User [Large Pharma, Generic] - Global Forecast to 2029
... Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing, Packaging}, End User [Large Pharma, Generic] - Global Forecast to 2029 The Pharmaceutical Contract Development and Manufacturing Market is ... Read More
-
Global Specialty Injectable Generics Market Size study, by Type (Drugs, Biologics), by Application (Oncology, Cardiovascular, Infectious Diseases, Central Nervous Systems, Autoimmune Disorders, Others) and Regional Forecasts 2022-2028
... approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Specialty Injectable Generics are drug therapies used for the ... Read More
-
Europe Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over the Counter Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Ner
... Respiratory, Hematology, Dermatology, Ophthalmology, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and by Country/Region (Germany, France, U.K., Italy, Spain, Russia, The Netherlands, Poland, Switzerland, Sweden, and Rest of Europe) - ... Read More
-
High Potency APIs Market/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region - Global forecast to 2027
... projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand ... Read More
-
Antiviral Drugs Market, by Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors and Others), by Type (Branded and Generics), by Application (HIV, Hepatitis, Herpes, Influenza, and Others),
... Pharmacies, Retail Pharmacies, and Online Pharmacies ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Antiviral drugs are prescription ... Read More
-
The 2023-2028 World Outlook for Generic Prescription Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Pure Generic Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Specialty Injectable Generics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Cold-Chain Generic Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Generic Injectables
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Generic Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Inhalation and Nasal Spray Generic Corticosteroid Drugs
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2023-2028 World Outlook for Generic Inhalation and Nasal Spray Drugs
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2023-2028 World Outlook for Inhalation and Nasal Spray Generic Drugs
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2023-2028 World Outlook for Specialty Generics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Generic Biosimilars
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Generics in Antivirals
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Generic Biosimilar Large Molecule Injectables
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2023-2028 World Outlook for Generic Oncology Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Generic Antiviral Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
